Sodium‐Glucose Cotransporter 2 Inhibitor Canagliflozin Antagonizes Salt‐Sensitive Hypertension Through Modifying Transient Receptor Potential Channels 3 Mediated Vascular Calcium Handling

Sodium‐Glucose Cotransporter 2 Inhibitor Canagliflozin Antagonizes Salt‐Sensitive Hypertension Through Modifying Transient Receptor Potential Channels 3 Mediated Vascular Calcium Handling

Background Salt‐sensitive hypertension is highly prevalent and associated with cardiorenal damage. Large clinical trials have demonstrated that SGLT2 (sodium‐glucose cotransporter 2) inhibitors exert hypotensive effect and cardiorenal protective benefits in patients with hypertension with and withou...

Full description

Bibliographic Details
Main Authors:	Yu Zhao, Li Li, Zongshi Lu, Yingru Hu, Hexuan Zhang, Fang Sun, Qiang Li, Chengkang He, Wentao Shu, Lijuan Wang, Tingbing Cao, Zhidan Luo, Zhencheng Yan, Daoyan Liu, Peng Gao, Zhiming Zhu
Format:	Article
Language:	English
Published:	Wiley 2022-08-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	NCX1 salt‐sensitive hypertension SGLT2 inhibitor TRPC3 vasocontraction
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.121.025328

Similar Items

Transient Receptor Potential Canonical (TRPC) Channels: Then and Now
by: Xingjuan Chen, et al.
Published: (2020-08-01)

A high-salt diet promotes hypertrophic scarring through TRPC3-mediated mitochondrial Ca2+ homeostasis dysfunction
by: Weijie Xia, et al.
Published: (2023-08-01)

Canagliflozin, an Inhibitor of the Na<sup>+</sup>-Coupled D-Glucose Cotransporter, SGLT2, Inhibits Astrocyte Swelling and Brain Swelling in Cerebral Ischemia
by: Bosung Shim, et al.
Published: (2023-09-01)

Emerging Roles of Diacylglycerol-Sensitive TRPC4/5 Channels
by: Michael Mederos y Schnitzler, et al.
Published: (2018-11-01)

Structural basis for human TRPC5 channel inhibition by two distinct inhibitors
by: Kangcheng Song, et al.
Published: (2021-03-01)

Canagliflozin and risk of amputation in patients with type 2 diabetes
by: T. M. Bukatina, et al.
Published: (2018-02-01)

Two dimensional finite element estimation of calcium ions in presence fo NCX and Buffers in Astrocytes
by: Brajesh Kumar Jha, et al.
Published: (2018-01-01)

Case Report: Post-gastrectomy reactive hyperinsulinemic hypoglicaemia: glucose trends before and after canagliflozin treatment
by: G. Bellastella, et al.
Published: (2023-08-01)

Clemizole and La3+ salts ameliorate angiotensin II‐induced glomerular hyperpermeability in vivo
by: Julia Dolinina, et al.
Published: (2021-05-01)

The Efficacy of Canagliflozin on Type 2 Diabetic Nephropathy in Male Rats
by: Manal M.G. Mourad*, et al.
Published: (2023-07-01)

Sleeve Gastrectomy Surgery Improves Glucose Metabolism by Downregulating the Intestinal Expression of Sodium–Glucose Cotransporter-3
by: Yixing Ren, et al.
Published: (2022-01-01)

Reconsidering the Role of Cyclooxygenase Inhibition in the Chemotherapeutic Value of NO-Releasing Aspirins for Lung Cancer
by: Antonia Martin-Martin, et al.
Published: (2019-05-01)

Effects of canagliflozin on myocardial microvascular density, oxidative stress, and proteomic profile
by: Sharif A. Sabe, et al.
Published: (2023-12-01)

Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus
by: Shusuke Yagi, et al.
Published: (2017-10-01)

Effects of TRPC1’s Lysines on Heteromeric TRPC5-TRPC1 Channel Function
by: Isaac S. Demaree, et al.
Published: (2024-12-01)

SGLT2 inhibitors for treatment of Type 2 diabetes mellitus: Focus on Canagliflozin
by: Santosh Kumar Singh, et al.
Published: (2014-01-01)

The Na+/Ca2+ exchanger NCX3 mediates Ca2+ entry into matrix vesicles to facilitate initial steps of mineralization in osteoblasts
by: Irshad A. Sheikh, et al.
Published: (2024-06-01)

Antiarrhythmic Effect of Ranolazine in Combination with Selective NCX-Inhibition in an Experimental Model of Atrial Fibrillation
by: Julian Wolfes, et al.
Published: (2020-10-01)

Computer Insight into the Molecular Level of Heart Failure. What is the Role of NCX?
by: M. Fischer, et al.
Published: (2008-01-01)

The Archaeal Na+/Ca2+ Exchanger (NCX_Mj) as a Model of Ion Transport for the Superfamily of Ca2+/CA Antiporters
by: Daniel Khananshvili
Published: (2021-07-01)

NCX1 is a new rest target gene: Role in cerebral ischemia
by: Luigi Formisano, et al.
Published: (2013-02-01)

The downregulation of NCXs is positively correlated with the prognosis of stage II–IV colon cancer
by: Zhixiu Xia, et al.
Published: (2021-06-01)

Effect and mechanism of transient receptor potential canonical channel 3 on hyperoxic lung injury in neonatal rats
by: Xingmeng Fu, et al.
Published: (2024-06-01)

Canagliflozin review – safety and efficacy profile in patients with T2DM
by: Jakher H, et al.
Published: (2019-02-01)

The Na+/glucose cotransporters: from genes to therapy
by: R. Sabino-Silva, et al.
Published: (2010-11-01)

TRPC expression in human periodontal ligament cells and the periodontal tissue of periodontitis mice: a preliminary study
by: Aeryun Kim, et al.
Published: (2023-09-01)

Correction to: Sodium‐Glucose Cotransporter 2 Inhibitor Canagliflozin Antagonizes Salt‐Sensitive Hypertension Through Modifying Transient Receptor Potential Channels 3 Mediated Vascular Calcium Handling
Published: (2023-04-01)

Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice
by: Νarjes Nasiri-Ansari, et al.
Published: (2018-07-01)

An evidence-based practice-oriented review focusing on canagliflozin in the management of type 2 diabetes
by: Messana JA, et al.
Published: (2017-02-01)

Association between the rs1465040 single-nucleotide polymorphism close to the transient receptor potential subfamily C member 3 (TRPC3) gene and postoperative analgesic requirements
by: Yoshinori Aoki, et al.
Published: (2015-03-01)

Unique responses of the fixed stoichiometric TRPC1–TRPC5 concatemer to G proteins
by: Hana Kang, et al.
Published: (2024-09-01)

TRPC6 Inactivation Reduces Albuminuria Induced by Protein Overload in Sprague Dawley Rats
by: Eun Young Kim, et al.
Published: (2022-06-01)

D‐Aspartate treatment attenuates myelin damage and stimulates myelin repair
by: Valeria de Rosa, et al.
Published: (2018-12-01)

Regulation of Cardiac Contractility by the Alpha 2 Subunit of the Na+/K+-ATPase
by: Jonas Skogestad, et al.
Published: (2022-06-01)

NCX1 and NCX3: Two new effectors of delayed preconditioning in brain ischemia
by: Giuseppe Pignataro, et al.
Published: (2012-01-01)

Canagliflozin: from glycemic control to improvement of cardiovascular and renal prognosis in patients with type 2 diabetes mellitus. Resolution of Advisory Board
by: M. V. Shestakova, et al.
Published: (2022-01-01)

Unmasking of normocalcemic primary hyperparathyroidism after sodium-glucose cotransporter-2 inhibitor initiation
by: Christodoulos Dolapsakis, et al.
Published: (2025-01-01)

An Overview of the Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Hematological Parameters in Diabetic Patients
by: Ghada Ahmed, et al.
Published: (2023-06-01)

Inhibitors of sodium-glucose cotransporter 2: risk of ketoacidosis
by: T. M. Bukatina, et al.
Published: (2018-02-01)

TRPC3/6 Channels Mediate Mechanical Pain Hypersensitivity via Enhancement of Nociceptor Excitability and of Spinal Synaptic Transmission
by: Zhi‐Chuan Sun, et al.
Published: (2024-11-01)